| 1 |
metastatic renal cell carcinoma
(2048 times)
|
Neoplasms
(1185 times)
|
OS (699 times)
PFS (571 times)
CI (218 times)
|
1992 Recombinant interferon alpha-2A combined with prednisone in metastatic renal-cell carcinoma: treatment results, serum interferon levels and the development of antibodies.
|
| 2 |
metastatic RCC
(161 times)
|
Neoplasms
(78 times)
|
RCC (143 times)
OS (31 times)
PFS (22 times)
|
2002 Therapeutic options in the management of renal cell carcinoma.
|
| 3 |
metastatic clear cell renal cell carcinoma
(24 times)
|
Neoplasms
(14 times)
|
TKI (6 times)
RCC (4 times)
VEGF (4 times)
|
2009 The medical management of metastatic renal cell carcinoma: integrating new guidelines and recommendations.
|
| 4 |
metastatic clear cell renal cancer
(6 times)
|
Neoplasms
(4 times)
|
VEGF (3 times)
HR (2 times)
OS (2 times)
|
2011 Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.
|
| 5 |
murine renal cell carcinoma
(2 times)
|
Neoplasms
(2 times)
|
G250-FMLs (1 time)
MLs (1 time)
RCC (1 time)
|
2001 Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes.
|
| 6 |
metastatic kidney cancer
(1 time)
|
Health Services
(1 time)
|
AEs (1 time)
DI (1 time)
mDI (1 time)
|
2022 Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.
|
| 7 |
metastatic or unresectable renal cell carcinoma
(1 time)
|
Prostatic Neoplasms
(1 time)
|
HCPs (1 time)
|
2023 Identifying the Needs of Health Care Providers in Advanced First-Line Renal Cell Carcinoma: A Mixed-Methods Research.
|
| 8 |
metastatic primary ccRCCs
(1 time)
|
Neoplasms
(1 time)
|
ccRCC (1 time)
nmRCC (1 time)
|
2016 Opposite prognostic roles of HIF1alpha and HIF2alpha expressions in bone metastatic clear cell renal cell cancer.
|
| 9 |
metastatic renal cell carcinoma with clear cell component
(1 time)
|
Neoplasms
(1 time)
|
Ave-Axi (1 time)
Ipi-Nivo (1 time)
OS (1 time)
|
2020 Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis.
|
| 10 |
multilocular RCC
(1 time)
|
Neoplasms
(1 time)
|
ccRCC (1 time)
chRCC (1 time)
FoxM1 (1 time)
|
2015 Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
|
A Search Service for Abbreviation / Long Form